EGFR and esophageal squamous cell carcinoma: The existence of low levels of EGFR mutation in ESCC indicates the presence of intra-tumor EGFR mutational heterogeneity, suggesting high sensitivity method should be preferred for studies exploring the correlation between EGFR mutations and TKI treatment in ESCC patients.